AcousticaBio
Biotechnology ResearchMassachusetts, United States11-50 Employees
AcousticaBio enables biologic drugs to move from infusion to injection. We help biopharmaceutical companies formulate new and existing biologics into ultra-high-concentration, small-volume subcutaneous injections, overcoming the viscosity, stability, and manufacturability challenges that typically limit injectable delivery. Powered by our proprietary, Harvard-patented acoustophoretic technology, we transform therapies traditionally administered through lengthy IV infusions into patient-friendly injections, without solvents or complex post-processing. The result: biologics that are easier to deliver, easier to manufacture, and better aligned with patient needs. Our platform supports a broad range of modalities, helping developers expand delivery options, improve patient experience, unlock new value across their pipelines, and set the stage for commercially viable drugs.
1-888-653-2347 
support@leadiq.com 
